Understanding PDA Technical Report 82 (TR 82): A Guide to Low Endotoxin Recovery
PDA Technical Report No. 82 (TR 82), "Low Endotoxin Recovery," provides a comprehensive guide for identifying, understanding, and mitigating the masking of endotoxins in pharmaceutical formulations. The 2019 report offers industry-backed strategies for conducting hold-time studies and managing the risks associated with false-negative results. Purchase the report at the PDA Bookstore . Technical Report No. 82: Low Endotoxin Recovery | PDA
If LER is identified, the report recommends several strategies to mitigate the risk: Optimizing the LAL assay procedure. pda technical report 82 pdf
Procedures for developing sound studies, including recommendations on endotoxin sources, spiking, container types, and temperature storage.
Navigating PDA Technical Report 82: A Definitive Guide to Low Endotoxin Recovery (LER) Studies Understanding PDA Technical Report 82 (TR 82): A
A preview of the report's structure is available via PDA's official site.
According to PDA TR 82, LER is defined as the inability to recover at least 50% of the spiked endotoxin activity over time. A key criterion is when two consecutive time points fail to achieve ≥ 50% recovery. 3. Mitigation Strategies Purchase the report at the PDA Bookstore
Including 12 detailed case studies (occupying 80 pages of the report) that analyze root causes and successful demasking protocols. Structure of the Report
The Technical Report provides a structured approach for managing LER, summarized by the following key principles: 1. Hold Time Studies (HTS)
The document is a proprietary technical report owned by the PDA.